Compare GRPN & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRPN | MDXG |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | 1734 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 646.1M | 530.2M |
| IPO Year | 2011 | 2007 |
| Metric | GRPN | MDXG |
|---|---|---|
| Price | $17.75 | $3.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $33.67 | $9.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,843,877,000.00 | $418,630,000.00 |
| Revenue This Year | $5.55 | N/A |
| Revenue Next Year | $6.63 | $13.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $9.17 | $3.03 |
| 52 Week High | $41.26 | $7.99 |
| Indicator | GRPN | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 50.50 |
| Support Level | $16.05 | $3.47 |
| Resistance Level | $18.81 | $3.84 |
| Average True Range (ATR) | 1.43 | 0.13 |
| MACD | -0.32 | 0.00 |
| Stochastic Oscillator | 32.65 | 46.25 |
Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.